456
Participants
Start Date
July 31, 2002
Primary Completion Date
October 31, 2003
Study Completion Date
October 31, 2003
PB127 for injectable suspension
0.175 mg/kg diluted in 150 mL Dextrose in Water 5% in glass bottles to be infused at 250 mL/hour until stead state achieve, 150 mL/hour during rest image acquisition, and 100-150 mL/hr during stress image acquistion. Single IV infusion, not to exceed 60 minutes.
University of Pittsburgh Cardiovascular Institute, Pittsburgh
Washington Hospital Center Cardiovascular Research Institute, Washington D.C.
The Cleveland Clinic Foundation Department of Cardiology, Cleveland
St. Louis University Medical Center, St Louis
The Center for Cardiovascular Studies Kramer & Crouse Cardiology, Shawnee Mission
University of Texas Health Sciences Center at San Antonio, San Antonio
Michael Morgan, MD, Phoenix
Long Beach VA Medical Center Cardiology Division, Long Beach
University of California San Diego Division of Cardiology, San Diego
San Francisco VA Medical Center NCIRE, San Francisco
Oregon Health Sciences University, Portland
Virginia Mason Medical Center, Seattle
Harborview Medical Center Department of Cardiology, Seattle
Northwest Cardiovascular Research Institute Spokane Cardiology, Spokane
New England Medical Center, Boston
Lead Sponsor
Point Biomedical
INDUSTRY